Search By Initial

Cas Index 2

• 2064269-82-3 | YK-029A (Catalog# : 20670)
• 2131223-85-1 | YW2065 (Catalog# : 20494)YW2065 has excellent anti-colorectal cancer effects in vitro and in vivo. YW2065 achi
• 2226534-49-0 | Y06137 (Catalog# : 193193)Y06137 is a potent and selective BET inhibitor, which binds to the BRD4(1) bromodomai
• 223499-30-7 | YM-58483 (BTP2) (Catalog# : 17109009)YM-58483/BTP2 is a blocker of store-operated Ca2+ entry (SOCE), which regulates the a
• 288250-47-5 | Y-320 (Catalog# : 52516)Y-320 is a new phenylpyrazoleanilide immunomodulator; inhibits IL-17 production by CD
• 2243882-74-6 | Zedoresertib (Catalog# : 26A023)Zedoresertib (Debio 0123) is a brain-penetrant, highly selective WEE1 kinase inhibito
• 2306303-35-3 | ZINC20451377 (Catalog# : 24132)ZINC20451377 is a small molecule that binds to hepatitis B surface antigen (HBsAg) wi
• 210345-04-3 | Z-LEHD-FMK (Catalog# : 24127)Z-LEHD-FMK is a potent, cell-permeable, and irreversible inhibitor of caspase-9. Z-LE
• 210344-98-2 | Z-IETD-FMK (Catalog# : 24126)MDK4982, also known as Z-IETD-FMK, is a potent, cell-permeable, irreversible inhibito
• 210344-95-9 | Z-DEVD-fmk (Catalog# : 24125)Z-DEVD-fmk is a cell-permeable, irreversible inhibitor of caspase-3. Caspase-3 is a c
• 2133852-18-1 | Zastaprazan ( JP-1366 ) (Catalog# : 24123)Zastaprazan, also known as JP-1366, is a proton pump inhibitor. JP-1366 mediates stro
• 2403703-30-8 | Zurletrectinib (Catalog# : 24104)Zurletrectinib is a tyrosine kinase inhibitor with potential as an antineoplastic age
• 2365193-22-0 | Zelasudil (Catalog# : 24014)Zelasudil is a potent, highly selective and orally-active inhibitor that targets Rho-
• 2134675-36-6 | Ziftomenib ( KO-539 ) (Catalog# : 24013)Ziftomenib is an oral, potent, and selective small molecule inhibitor that targets th
• 2728667-27-2 | Zongertinib (Catalog# : 24011)Zongertinib [BI 1810631] is a human epidermal growth factor receptor 2 (HER2) inhibit
• 2272904-53-5 | Zasocitinib (Catalog# : 24010)Zasocitinib is under development for the treatment of moderate to severe plaque psori
• 2173389-57-4 | Zilurgisertib (Catalog# : 20657)Zilurgisertib (earlier known as INCB 00928) is an activin receptor-like kinase-2 (ALK
• 2201048-82-8 | Zagociguat (Catalog# : 20628)Zagociguat is a guanylate cyclase activator.
• 2739829-00-4 | Zidesamtinib ( NVL-520 ) (Catalog# : 20524)Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in
• 2648641-36-3 | Zotizalkib ( TPX-0131 ) (Catalog# : 20318)TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated
• 2254001-81-3 | ZK824859 (Catalog# : 2071513)ZK824859 is a potent uPA inhibitor as a potential treatment for multiple sclerosis. Z
• 2229042-77-5 | ZL0454 (Catalog# : 193281)ZL0454 is a potent and selective BRD4 inhibitor. ZL0454 reduces airway inflammation a
• 2031177-48-5 | ZM223 (Catalog# : 19352)ZM223 is a novel non-sulfamide NEDD8 activating enzyme inhibitor that inhibits HCT116
• 210344-98-2 | Z-IETD-FMK (Catalog# : 16122771)Z-IETD-FMK is a specific Caspase-8 inhibitor.Z-IETD-FMK, which inhibits the cleavage
• 221877-54-9 | Zotarolimus (Catalog# : 161009018)It is a semi-synthetic derivative of rapamycin. It was designed for use in stents wit
• 210344-95-9 | Z-DEVD-FMK (Catalog# : 16062112)Z-DEVD-FMK(Caspase-3 Inhibitor) is a specific, irreversible Caspase-3 inhibitor, and
• 25775-90-0 | Zucapsaicin (Catalog# : 121415)Comig soon!
• 208260-29-1 | ZM 336372 (Catalog# : 52239)ZM 336372 is a potent and selective c-Raf inhibitor with IC50 of 70 nM, 10-fold selec